Marksans Pharma Ltd. | Mid-cap | Healthcare
₹242.80
0.87%
| Marksans Pharma Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 26.2B
Gross Profit 14.8B 56.39%
Operating Income 4.5B 16.98%
Net Income 3.8B 14.59%

Balance Sheet Metrics

Total Assets 32.4B
Total Liabilities 7.5B
Shareholders Equity 24.9B
Debt to Equity 0.30

Cash Flow Metrics

Operating Cash Flow 2.4B
Free Cash Flow 337.4M

Revenue & Profitability Trend

Marksans Pharma Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 26.2B 21.7B 18.5B 14.8B 13.7B
Cost of Goods Sold 11.4B 10.9B 9.6B 7.2B 6.2B
Gross Profit 14.8B 10.8B 8.9B 7.6B 7.5B
Operating Expenses 6.0B 3.1B 2.8B 2.9B 1.9B
Operating Income 4.5B 3.9B 3.1B 2.2B 3.2B
Pre-tax Income 5.0B 4.2B 3.4B 2.5B 3.0B
Income Tax 1.2B 1.1B 723.3M 607.0M 636.3M
Net Income 3.8B 3.1B 2.7B 1.9B 2.4B
EPS (Diluted) - ₹6.92 ₹6.41 ₹4.51 ₹5.83

Income Statement Trend

Marksans Pharma Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 22.0B 18.6B 16.8B 12.0B 9.0B
Non-Current Assets 10.4B 8.2B 5.2B 4.4B 3.3B
Total Assets 32.4B 26.8B 21.9B 16.4B 12.3B
Liabilities
Current Liabilities 4.8B 3.9B 3.4B 3.6B 3.0B
Non-Current Liabilities 2.7B 2.1B 843.3M 609.1M 245.0M
Total Liabilities 7.5B 6.0B 4.3B 4.2B 3.2B
Equity
Total Shareholders Equity 24.9B 20.9B 17.7B 12.2B 9.1B

Balance Sheet Composition

Marksans Pharma Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 5.0B 4.2B 3.4B 2.5B 3.0B
Operating Cash Flow 2.4B 2.7B 2.2B 1.1B 1.4B
Investing Activities
Capital Expenditures -1.7B -2.1B -532.5M -463.0M -459.1M
Investing Cash Flow -828.1M -1.7B -2.7B -891.5M -459.1M
Financing Activities
Dividends Paid -271.9M -226.6M -101.7M -105.8M -40.9M
Financing Cash Flow -392.0M -351.6M 2.2B 1.0B -43.0M
Free Cash Flow 337.4M 215.7M 1.8B 529.3M 1.3B

Cash Flow Trend

Marksans Pharma Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 30.86
Forward P/E 18.92
Price to Book 4.76
Price to Sales 4.48

Profitability Ratios

Profit Margin 14.51%
Operating Margin 14.54%
Return on Equity 16.73%
Return on Assets 9.40%

Financial Health

Current Ratio 4.62
Debt to Equity 12.93
Beta 1.38

Per Share Data

EPS (TTM) ₹8.40
Book Value per Share ₹54.49
Revenue per Share ₹57.89

Financial data is updated regularly. All figures are in the company's reporting currency.